1. Adachi, Y., Reynolds, P. N., Yamamoto, M., Grizzle, W. E., Overturf, K., Matsubara, S., Muramatsu, T. and Curiel, D. T. (2000): Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors. Cancer Research 60, 4305–10.
2. Anderson, W. F. (1998): Human gene therapy. Nature 392, 25–30.
3. Aprikian, A. G., Cordon-Cardo, C., Fair, W. R., Zhang, Z. F., Bazinet, M, Hamdy, S. M. and Reuter, V. E.(1994): Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. Journal of Urology 151, 914–9.
4. Asano, M., Yukita, A., Matsumoto, T., Kondo, S. and Suzuki, H. (1995): Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factorl21. Cancer Research 55, 5296–301.
5. Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D. and Gilboa, E. (1997): Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. Journal of Experimental Medicine 186, 1177–82.